*.*

Source link : https://www.newshealth.biz/health-news/does-dabrafenib-trametinib-improve-survival-in-melanoma/

TOPLINE: In patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib reduces the risk for death by 20% compared with placebo, though the overall survival benefit does not reach statistical significance. The combination lowers the risk for death by a greater degree — 25% — in patients with a BRAF V600E mutation. […]

Author : News Health

Publish date : 2024-07-02 13:24:10

Copyright for syndicated content belongs to the linked Source.

........
....................................................................................................